Masoud Ghaemmaghami, MD | |
1700 Prairie City Rd, Folsom, CA 95630-9594 | |
(916) 351-4800 | |
(916) 351-4899 |
Full Name | Masoud Ghaemmaghami |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 12 Years |
Location | 1700 Prairie City Rd, Folsom, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518220656 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | A132472 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Of Folsom | Folsom, CA | Hospital |
University Of California Davis Medical Center | Sacramento, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dignity Health Medical Foundation | 7810800661 | 1209 |
News Archive
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Pregnant women with thyroid function test results in the upper half of the normal range have an increased chance of miscarriage, even when they lack thyroid-harming antibodies, according to a new study. The results, which the authors say show the need to change screening practices for pregnant women, will be presented at The Endocrine Society's 92nd Annual Meeting, ENDO 2010, in San Diego on June 22 by Alex Stagnaro-Green, M.D., senior author and senior associate dean for education at The George Washington University School of Medicine and Health Sciences.
Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.
MannKind Corporation today announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA™ (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
› Verified 5 days ago
Entity Name | Dignity Health Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709 |
News Archive
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Pregnant women with thyroid function test results in the upper half of the normal range have an increased chance of miscarriage, even when they lack thyroid-harming antibodies, according to a new study. The results, which the authors say show the need to change screening practices for pregnant women, will be presented at The Endocrine Society's 92nd Annual Meeting, ENDO 2010, in San Diego on June 22 by Alex Stagnaro-Green, M.D., senior author and senior associate dean for education at The George Washington University School of Medicine and Health Sciences.
Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.
MannKind Corporation today announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA™ (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Masoud Ghaemmaghami, MD 3400 Data Dr, Rancho Cordova, CA 95670-7956 Ph: () - | Masoud Ghaemmaghami, MD 1700 Prairie City Rd, Folsom, CA 95630-9594 Ph: (916) 351-4800 |
News Archive
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Pregnant women with thyroid function test results in the upper half of the normal range have an increased chance of miscarriage, even when they lack thyroid-harming antibodies, according to a new study. The results, which the authors say show the need to change screening practices for pregnant women, will be presented at The Endocrine Society's 92nd Annual Meeting, ENDO 2010, in San Diego on June 22 by Alex Stagnaro-Green, M.D., senior author and senior associate dean for education at The George Washington University School of Medicine and Health Sciences.
Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.
MannKind Corporation today announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA™ (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
› Verified 5 days ago
Janani Kumaresan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1700 Prairie City Rd, Folsom, CA 95630 Phone: 916-351-4800 Fax: 916-351-4889 | |
Dr. Rajeswari Jayaraman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1650 Creekside Dr, Folsom, CA 95630 Phone: 916-986-4426 Fax: 916-986-4434 | |
Vijay P. Singh, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1650 Creekside Dr, Folsom, CA 95630 Phone: 916-983-7461 | |
Dr. Baljit S Sivia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1650 Creekside Dr, Folsom, CA 95630 Phone: 916-986-2345 Fax: 916-986-2345 | |
Harkanwal Singh, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1700 Prairie City Rd, Folsom, CA 95630 Phone: 916-351-4800 Fax: 916-351-4899 | |
Samira Kirmiz, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1730 Prairie City Rd, Suite 120, Folsom, CA 95630 Phone: 916-351-4800 Fax: 916-351-4899 |